Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Anti-Cancer Agents in Medicinal Chemistry|February 4, 2011
Protein phosphatase 2A as a potential target for anticancer therapyPeter Kalev, Anna A SablinaRadiation Research|April 29, 2009
The complexity of double-strand break ends is a factor in the repair pathway choiceEmil Mladenov, Peter Kalev, Boyka AnachkovaDNA Repair|May 10, 2015
Emerging role of protein phosphatases changes the landscape of phospho-signaling in DNA damage responseXiao-Feng Zheng, Peter Kalev, Dipanjan ChowdhuryCancer Research|October 23, 2012
Loss of PPP2R2A inhibits homologous recombination DNA repair and predicts tumor sensitivity to PARP inhibitionPeter Kalev, Michal Simicek, Iria Vazquez, et al.Cancer Research|January 30, 2014
p16INK4a impairs homologous recombination-mediated DNA repair in human papillomavirus-positive head and neck tumorsRüveyda Dok, Peter Kalev, Evert Jan Van Limbergen, et al.Molecular Cell|April 8, 2014
Dephosphorylation enables the recruitment of 53BP1 to double-strand DNA breaksDong-Hyun Lee, Sanket S Acharya, Mijung Kwon, et al.Nature Cell Biology|September 24, 2013
The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune responseMichal Simicek, Sam Lievens, Mathias Laga, et al.Cancer Cell|January 24, 2018
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing SarcomaAmanda Balboni Iniguez, Björn Stolte, Emily Jue Wang, et al.Nature Medicine|July 5, 2016
p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivityCarmen Adriaens, Laura Standaert, Jasmine Barra, et al.Journal of Medicinal Chemistry|April 8, 2021
Discovery of AG-270, a First-in-Class Oral MAT2A Inhibitor for the Treatment of Tumors with Homozygous <i>MTAP</i> DeletionZenon Konteatis, Jeremy Travins, Stefan Gross, et al.Pageof 2